134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study)
| Autor: | Shozo Ohsumi, H. Tuji, Tadahiko Shien, Masato Takahashi, Yutaka Ogasawara, Naruto Taira, Fumikata Hara, Seiji Yoshitomi, Hiroyoshi Doihara, Shoichiro Ohtani, Kinya Matsuoka, Masahiko Ikeda |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty business.industry Phases of clinical research Hematology medicine.disease Metastatic breast cancer 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine chemistry Trastuzumab 030220 oncology & carcinogenesis Internal medicine medicine Anti her2 business Eribulin medicine.drug |
| Zdroj: | Annals of Oncology. 27 |
| ISSN: | 1569-8041 0923-7534 |
| DOI: | 10.1093/annonc/mdw577.017 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|